Supriya Lifescience Limited (NSE:SUPRIYA)
India
· Delayed Price · Currency is INR 695.00
-14.45 (-2.04%)
May 16, 2025, 3:29 PM IST
Supriya Lifescience Cash Flow Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2018 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 | 2018 - 2019 |
| Net Income | 1,191 | 898.57 | 1,518 | 1,236 | 734.03 | Upgrade
|
| Depreciation & Amortization | 154.45 | 114.52 | 97.52 | 63.69 | 59.84 | Upgrade
|
| Other Amortization | 3.66 | 3.63 | 3.66 | 3.92 | 3.92 | Upgrade
|
| Loss (Gain) From Sale of Assets | - | 1.11 | - | - | - | Upgrade
|
| Other Operating Activities | -44.76 | -43.63 | -87.74 | 123.52 | -3.18 | Upgrade
|
| Change in Accounts Receivable | -270.19 | 305.19 | -416.83 | -218.7 | 74.65 | Upgrade
|
| Change in Inventory | 305.21 | -234.58 | -198.32 | -230.22 | -187.26 | Upgrade
|
| Change in Accounts Payable | -46.59 | 152.56 | -20.5 | 16.53 | 52.64 | Upgrade
|
| Change in Other Net Operating Assets | -159.85 | -561.32 | -407.88 | -235.78 | 425.98 | Upgrade
|
| Operating Cash Flow | 1,133 | 636.05 | 488.01 | 758.89 | 1,161 | Upgrade
|
| Operating Cash Flow Growth | 78.14% | 30.34% | -35.69% | -34.61% | 138.46% | Upgrade
|
| Capital Expenditures | -1,457 | -1,079 | -599.04 | -482.41 | -245.25 | Upgrade
|
| Sale of Property, Plant & Equipment | - | - | 0.82 | 14.4 | - | Upgrade
|
| Investment in Securities | -385 | -252.43 | - | - | - | Upgrade
|
| Other Investing Activities | 105.8 | 94.99 | - | - | - | Upgrade
|
| Investing Cash Flow | -1,736 | -1,237 | -598.22 | -468.01 | -245.25 | Upgrade
|
| Short-Term Debt Repaid | -166.25 | -46.7 | -486.07 | -92.73 | -18.85 | Upgrade
|
| Long-Term Debt Repaid | -3.54 | -2.78 | -7.63 | -23.93 | -57.43 | Upgrade
|
| Total Debt Repaid | -169.79 | -49.48 | -493.7 | -116.66 | -76.28 | Upgrade
|
| Net Debt Issued (Repaid) | -169.79 | -49.48 | -493.7 | -116.66 | -76.28 | Upgrade
|
| Issuance of Common Stock | - | - | 2,000 | - | - | Upgrade
|
| Common Dividends Paid | -48.29 | -48.29 | -43.91 | -39.56 | -176.46 | Upgrade
|
| Other Financing Activities | -5.51 | -4.99 | 34.13 | 11.06 | -39.56 | Upgrade
|
| Financing Cash Flow | -223.59 | -102.76 | 1,497 | -145.16 | -292.3 | Upgrade
|
| Miscellaneous Cash Flow Adjustments | 0.01 | -0.01 | - | 0.01 | - | Upgrade
|
| Net Cash Flow | -826.26 | -703.26 | 1,386 | 145.73 | 623.07 | Upgrade
|
| Free Cash Flow | -323.48 | -443.05 | -111.03 | 276.48 | 915.37 | Upgrade
|
| Free Cash Flow Growth | - | - | - | -69.80% | 119.37% | Upgrade
|
| Free Cash Flow Margin | -5.67% | -9.61% | -2.10% | 7.07% | 28.61% | Upgrade
|
| Free Cash Flow Per Share | -4.02 | -5.50 | -1.38 | 3.78 | 12.51 | Upgrade
|
| Cash Interest Paid | 5.51 | 4.99 | 36.58 | 38.74 | 61.29 | Upgrade
|
| Cash Income Tax Paid | 376.45 | 306.8 | 609.62 | 299.94 | 270.05 | Upgrade
|
| Levered Free Cash Flow | -528.68 | -582.63 | -165.84 | 73.81 | 573.29 | Upgrade
|
| Unlevered Free Cash Flow | -496.5 | -563.35 | -139.6 | 99.31 | 616.1 | Upgrade
|
| Change in Net Working Capital | 199.57 | 334.7 | 918.86 | 525.8 | -167.54 | Upgrade
|
Updated Jan 24, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.